PERIPHERAL VENOUS DISEASE

This adverse event was reported 4088 times

These drugs are most commonly taken by patients reporting PERIPHERAL VENOUS DISEASE:

# Drug Count
0 METHOTREXATE SODIUM 1689
1 ADALIMUMAB 1687
2 DICLOFENAC SODIUM 1681
3 RITUXIMAB 1675
4 SECUKINUMAB 1662
5 DICLOFENAC 1618
6 LEFLUNOMIDE 1608
7 METHOTREXATE 1605
8 PREDNISONE 1513
9 ALENDRONATE SODIUM 1492
See all common drugs associated with PERIPHERAL VENOUS DISEASE

PERIPHERAL VENOUS DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HYDROCORTISONE BUTYRATE 291 0.1473
1 CAFFEINE CITRATE 298 0.1277
2 DICLOFENAC POTASSIUM TABLETS 983 0.1134
3 GOLIMUMAB 1365 0.1084
4 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 69 0.1049
5 NICOTINAMIDE 241 0.0943
6 TRIPROLIDINE HYDROCHLORIDE 18 0.0923
7 PSEUDOEPHEDRINE HCL 992 0.0906
8 DICLOFENAC POTASSIUM 983 0.0889
9 CORTISONE ACETATE 980 0.0784
See all drugs enriched for association with PERIPHERAL VENOUS DISEASE

PERIPHERAL VENOUS DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 733 1.0654
1 Endoglycosidase [EPC] 200 0.1079
2 Interleukin-17A Antagonist [EPC] 1668 0.0447
3 Provitamin D2 Compound [EPC] 1130 0.0380
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 271 0.0311
5 Antirheumatic Agent [EPC] 1608 0.0152
6 Aminosalicylate [EPC] 1485 0.0147
7 beta3-Adrenergic Agonist [EPC] 658 0.0138
8 Interleukin-6 Receptor Antagonist [EPC] 1523 0.0110
9 Histamine-1 Receptor Antagonist [EPC] 914 0.0108
See all drug classes enriched for association with PERIPHERAL VENOUS DISEASE